Loading...
menu
Search
Features
Markets
News
Resources
Pricing
Home
ETF
GALT
GALT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest GALT ETF News Today | Earnings, Events & Price Alerts
GALT News
Galectin Therapeutics Under Investigation, Stock Plummets 28.9%
Jan 22 2026
PRnewswire
Galectin Therapeutics Under Investigation, Stock Plummets 28.9%
Jan 15 2026
PRnewswire
Galectin Therapeutics Faces 28.9% Stock Drop Following FDA Response on Belapectin Trial
Jan 08 2026
PRnewswire
Galectin Therapeutics Faces Securities Fraud Investigation as Stock Plummets 28.9%
Jan 06 2026
Globenewswire
Galectin Therapeutics Faces 28.9% Stock Drop Following FDA Response on Belapectin Trial
Dec 30 2025
Globenewswire
Galectin Therapeutics Shares Plunge 28.9% Following FDA Response on Belapectin Development
Dec 30 2025
Businesswire
Galectin Secures $10M Credit Line, FDA Provides Guidance on Regulatory Pathway
Dec 26 2025
NASDAQ.COM
Galectin Therapeutics Receives FDA Feedback to Advance Belapectin Development
Dec 22 2025
NASDAQ.COM
Galectin Therapeutics (GALT) Price Target Raised by 83.33% to $11.22
Dec 21 2025
NASDAQ.COM
Galectin Therapeutics Receives FDA Feedback to Advance Belapectin Development
Dec 19 2025
Globenewswire
Galectin Therapeutics Receives FDA Feedback to Advance Belapectin Development
Dec 19 2025
Newsfilter
Galectin Experiences Decline Following Update on MASH Candidate Belapectin and New $10M Credit Line
Dec 19 2025
SeekingAlpha
Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers
Dec 19 2025
NASDAQ.COM
Stitch Fix Reports Q4 Earnings, Alongside Transocean, MBX Biosciences, and Other Major Stocks Declining in Thursday's Pre-Market Trading
Sep 25 2025
Benzinga
Galectin Therapeutics Inc. (GALT) Sees 7.48% Increase Over the Past Week: Key Insights
Sep 12 2025
NASDAQ.COM
Stocks of MODD, GALT, XCUR, PEPG, and BSGM Surge in After-Hours Trading Following Clinical Developments and Strategic Actions
Sep 12 2025
NASDAQ.COM
Show More News
